NY1 covered World Hepatitis Day 2015, with a focus on Hep C in the Bronx and the Project INSPIRE Hep C Care Coordination program, in the segment on their English and Spanish language channels.
Last Updated on January 25, 2020 by HepFree NYC
Related Articles
-
Olysio-Sovaldi Combo Becomes 2nd FDA-approved All-oral HCV Treatment
Olysio has been approved by the FDA, in combination with Sovaldi, for the treatment of Hepatitis C. It is substantially more expensive than Harvoni; although it depends on treatment time, a 12-week Harvoni treatment costs $94,500, compared to the Olysio-Sovaldi 12-week tag of $1...
-
Dear Colleague Letter | Hep B & C Screening & Treatment Guidance 2020 (NYC Health Dept)
In March 2020, the United States Preventive Services Task Force recommended one-time screening for hepatitis C in people aged 18-79. Simplified treatment guidance has been developed for hepatitis B and C.
-
Press Release | 2014 NYC Hep B Awareness Week Press Conference
2014 NYC Hep B Awareness Week Press Conference The Council of the City of New York Office of Communications City Hall New York, NY 10007 July 21, 2014 Contacts: Sam Spokony : 212-788-7259, sspokony@council.nyc.gov Jefferey LeFrancois : 212-564-7757, jlefrancois@council.nyc.gov Jo...
-
Presentation | Hep C Prior Authorization Tips from the Pros
his presentation includes tips from providers experienced with advocating successfully for hepatitis C medication coverage for their patients.
-
Hepatitis A, B and C in New York City: 2022 Annual Report
The Hepatitis A, B and C in NYC: 2022 Annual Report provides the latest surveillance and programmatic data on viral hepatitis in NYC.
-
Open for Public Comment: NY State Medicaid Sovaldi Clinical Criteria
The draft clinical criteria for the use of Hep C medication Sofosbuvir (Sovaldi) was presented to the NYS Department Of Health Drug Utilization Review Board (DURB) on Thursday, September 18, 2014.
-
Updated News | NYS Hep C Learning Collaborative Launched!
This web-based, public-facing, interactive dashboard system will present targets and key outcomes of the initiative to eliminate Hep C in NYS and serve as a comprehensive source of local and statewide Hep C-related data.
-
NYS DOH Removes Hep C Med Restrictions in FFS Medicaid
The NYS Drug Utilization Review Board voted to eliminate most restrictions on prescribing hepatitis C medications for all Medicaid fee-for-service patients.
